Adalimumab for Pediatric Sympathetic Ophthalmia
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/08/01
-
Journal
-
Indian UGC (journal)
-
Citations11
-
Joon-Bom Kim Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
-
Abdallah Jeroudi Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
-
Sheila T. Angeles-Han Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia3Children’s Hospital of Atlanta, Atlanta, Georgia
-
Hans E. Grossniklaus Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
-
Steven Yeh Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia
Cite
Kim, Joon-Bom, et al. “Adalimumab for Pediatric Sympathetic Ophthalmia”. JAMA Ophthalmology, vol. 132, no. 8, 2014, p. 1022, https://doi.org/10.1001/jamaophthalmol.2014.426.
Kim, J.-B., Jeroudi, A., Angeles-Han, S. T., Grossniklaus, H. E., & Yeh, S. (2014). Adalimumab for Pediatric Sympathetic Ophthalmia. JAMA Ophthalmology, 132(8), 1022. https://doi.org/10.1001/jamaophthalmol.2014.426
Kim, Joon-Bom, Abdallah Jeroudi, Sheila T. Angeles-Han, Hans E. Grossniklaus, and Steven Yeh. “Adalimumab for Pediatric Sympathetic Ophthalmia”. JAMA Ophthalmology 132, no. 8 (2014): 1022. https://doi.org/10.1001/jamaophthalmol.2014.426.
Kim JB, Jeroudi A, Angeles-Han ST, Grossniklaus HE, Yeh S. Adalimumab for Pediatric Sympathetic Ophthalmia. JAMA Ophthalmology. 2014;132(8):1022.
Journal Categories
Medicine
Medicine (General)
Medicine
Ophthalmology
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Sympathetic Ophthalmia: Demographic Characteristics, Clinical Findings, and Treatment Results | Turkish Journal of Ophthalmology |
| 2023 | |
| Sympathetic Ophthalmia - An Overview | Ocular Immunology and Inflammation |
| 3 | 2022 |
The Ruptured Globe, Sympathetic Ophthalmia, and the 14-Day Rule | Ophthalmic Plastic & Reconstructive Surgery |
| 2022 | |
| Sympathetic ophthalmia: A comprehensive update | Indian Journal of Ophthalmology |
| 1 | 2022 |
| Sympathetic Ophthalmia: Where Do We Currently Stand on Treatment Strategies? | Clinical Ophthalmology |
| 2021 |
Citations Analysis
The category
Medicine: Ophthalmology 7
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Prednisone and was published in 2014. The most recent citation comes from a 2023 study titled Sympathetic Ophthalmia: Demographic Characteristics, Clinical Findings, and Treatment Results. This article reached its peak citation in 2022, with 3 citations. It has been cited in 11 different journals, 27% of which are open access. Among related journals, the Turkish Journal of Ophthalmology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.